Join
Live feed
·
INSIDERFilingvia Quantisnow
Sangamo Therapeutics Inc. logo

SVP-CHIEF DEVELOPMENT OFFICER Dubois-Stringfellow Nathalie sold $89,184 worth of shares (345,942 units at $0.26), decreasing direct ownership by 51% to 332,769 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SGMO· Sangamo Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGMO (Sangamo Therapeutics Inc.) and more on Quantisnow.